Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mark Jackson

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Journal of the American Academy of Dermatology|December 20, 2022
Unmet needs for patients with seborrheic dermatitisJ Mark Jackson, Andrew Alexis, Matthew Zirwas, et al.
Journal of Drugs in Dermatology : JDD|April 3, 2013
Efficacy of extended-release 45 mg oral minocycline and extended-release 45 mg oral minocycline plus 15% azelaic acid in the treatment of acne rosaceaJ Mark Jackson, Leon H Kircik, Douglas J Lorenz
Journal of Drugs in Dermatology : JDD|March 11, 2010
A randomized, investigator-blinded trial to assess the antimicrobial efficacy of a benzoyl peroxide 5%/ clindamycin phosphate 1% gel compared with a clindamycin phosphate 1.2%/tretinoin 0.025% gel in the topical treatment of acne vulgarisJ Mark Jackson, Juian-Juian Jan Fu, Jennifer L Almekinder
Dermatology and Therapy|November 15, 2017
DFD-01 Reduces Transepidermal Water Loss and Improves Skin Hydration and FlexibilityJ Mark Jackson, Gary L Grove, Kent Allenby, et al.
Cutis|March 19, 2005
Hydrocortisone butyrate 0.1% cream in the treatment of chronic dermatitisJoseph F Fowler, Anthony F Fransway, J Mark Jackson, et al.
JBJS Reviews|January 31, 2017
Bacterial Sport-Related Skin and Soft-Tissue Infections (SSTIs): An Ongoing Problem Among a Diverse Range of AthletesJustin J Mitchell, J Mark Jackson, Azam Anwar, et al.
Journal of the American Academy of Dermatology|August 21, 2023
Cardiovascular comorbidities in atopic dermatitis: Potential implications for the use of Janus kinase inhibitorsJ Mark Jackson, Amanda Althoff, Lawrence Rasouliyan, et al.
Journal of Drugs in Dermatology : JDD|June 3, 2010
Mycophenolate mofetil for the treatment of chronic dermatitis: an open-label study of 16 patientsJ Mark Jackson, Joseph F Fowler, Jeffrey P Callen, et al.
The Journal of Dermatological Treatment|June 16, 2017
Defining treatment success in rosacea as 'clear' may provide multiple patient benefits: results of a pooled analysisGuy Webster, Martin Schaller, Jerry Tan, et al.
Journal of the American Academy of Dermatology|February 21, 2006
Treatment of recurrent Sweet's syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanerceptPaul S Yamauchi, Logan Turner, Nicholas J Lowe, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Journal of the American Academy of Dermatology|December 20, 2022
Unmet needs for patients with seborrheic dermatitisJ Mark Jackson, Andrew Alexis, Matthew Zirwas, et al.
Journal of Drugs in Dermatology : JDD|April 3, 2013
Efficacy of extended-release 45 mg oral minocycline and extended-release 45 mg oral minocycline plus 15% azelaic acid in the treatment of acne rosaceaJ Mark Jackson, Leon H Kircik, Douglas J Lorenz
Journal of Drugs in Dermatology : JDD|March 11, 2010
A randomized, investigator-blinded trial to assess the antimicrobial efficacy of a benzoyl peroxide 5%/ clindamycin phosphate 1% gel compared with a clindamycin phosphate 1.2%/tretinoin 0.025% gel in the topical treatment of acne vulgarisJ Mark Jackson, Juian-Juian Jan Fu, Jennifer L Almekinder
Dermatology and Therapy|November 15, 2017
DFD-01 Reduces Transepidermal Water Loss and Improves Skin Hydration and FlexibilityJ Mark Jackson, Gary L Grove, Kent Allenby, et al.
Cutis|March 19, 2005
Hydrocortisone butyrate 0.1% cream in the treatment of chronic dermatitisJoseph F Fowler, Anthony F Fransway, J Mark Jackson, et al.
JBJS Reviews|January 31, 2017
Bacterial Sport-Related Skin and Soft-Tissue Infections (SSTIs): An Ongoing Problem Among a Diverse Range of AthletesJustin J Mitchell, J Mark Jackson, Azam Anwar, et al.
Journal of the American Academy of Dermatology|August 21, 2023
Cardiovascular comorbidities in atopic dermatitis: Potential implications for the use of Janus kinase inhibitorsJ Mark Jackson, Amanda Althoff, Lawrence Rasouliyan, et al.
Journal of Drugs in Dermatology : JDD|June 3, 2010
Mycophenolate mofetil for the treatment of chronic dermatitis: an open-label study of 16 patientsJ Mark Jackson, Joseph F Fowler, Jeffrey P Callen, et al.
The Journal of Dermatological Treatment|June 16, 2017
Defining treatment success in rosacea as 'clear' may provide multiple patient benefits: results of a pooled analysisGuy Webster, Martin Schaller, Jerry Tan, et al.
Journal of the American Academy of Dermatology|February 21, 2006
Treatment of recurrent Sweet's syndrome with coexisting rheumatoid arthritis with the tumor necrosis factor antagonist etanerceptPaul S Yamauchi, Logan Turner, Nicholas J Lowe, et al.
Pageof 4